Dilgly UniCap Inhalation Capsule 50 mcg contains Glycopyrronium Bromide 50 mcg, a long-acting muscarinic antagonist (LAMA) used for the management of chronic obstructive pulmonary disease (COPD). Glycopyrronium works by blocking muscarinic receptors in the airways, reducing bronchoconstriction and improving airflow. This helps alleviate symptoms such as shortness of breath, wheezing, and frequent coughing, which are common in COPD patients.
COPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and frequent exacerbations. Dilgly UniCap helps patients maintain better lung function, reduce flare-ups, and improve daily activity levels. The inhalation capsule format allows direct delivery of medication to the lungs, providing rapid onset of action and minimizing systemic side effects compared to oral therapy.
This once-daily therapy is particularly beneficial for patients with moderate to severe COPD, including those with chronic bronchitis or emphysema, helping them manage symptoms effectively while improving overall quality of life.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Dilgly UniCap Inhalation Capsule 50 mcg is indicated for:
Maintenance treatment of moderate to severe COPD
Reduction of dyspnea (shortness of breath) and improvement of lung function
Prevention of COPD exacerbations
Symptomatic relief for patients with chronic bronchitis or emphysema
Provides long-acting bronchodilation by blocking muscarinic receptors
Reduces airway constriction and mucus secretion, improving airflow
Relieves symptoms like shortness of breath, wheezing, and chronic cough
Convenient once-daily inhalation for sustained symptom control
Direct lung delivery ensures rapid onset and lower systemic exposure
Glycopyrronium Bromide is a selective muscarinic M1 and M3 receptor antagonist. These receptors, located on airway smooth muscles, mediate bronchoconstriction and mucus production when activated by acetylcholine. By blocking these receptors, Glycopyrronium relaxes the airway muscles, reduces mucus secretion, and prevents airway narrowing, resulting in improved lung function and easier breathing.
The recommended dose is one inhalation capsule (50 mcg) once daily using a compatible dry powder inhaler (DPI).
Do not swallow the capsule; it must be inhaled using the prescribed inhaler device.
Take the capsule at the same time each day to maintain consistent therapeutic effect.
Do not exceed the recommended dose.
Not for use in acute bronchospasm; intended only for maintenance therapy.
Use cautiously in patients with glaucoma, urinary retention, or severe cardiovascular disease.
Inform your healthcare provider of all other medications to avoid potential interactions.
Seek medical attention if experiencing severe palpitations, chest pain, or difficulty breathing.
Not recommended for children under 18 years unless prescribed by a physician.
Dilgly UniCap Inhalation Capsule 50 mcg is generally well tolerated. Side effects may include:
Dry mouth
Cough or throat irritation
Headache
Rarely, blurred vision or urinary retention
Mild dizziness or palpitations
Most side effects are mild and often resolve with continued use. Dose adjustments or supportive care may reduce adverse effects.
Store below 30°C in a cool, dry place, away from direct sunlight and moisture. Keep capsules out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet